Dataset: Diatom metabolites

Name: Diatom metabolites under P-limited and P-replete growth from laboratory cultures in July of 2013
Published: 2021-08-27
Keywords: Thalassiosira pseudonana, phytoplankton, Carbon cycle, Fourier Transform Ion Cyclotron Resonance Mass Spectrometry, Liquid Chromatography-Mass Spectrometry, Targeted Metabolites, Untargeted Metabolites, oceans

View Data: Data not available yet

Cite This Dataset

Temporal Extent: 2013-06

Project:

Identifying and quantifying new markers of microbially mediated nutrient flow in the ocean (Microbial metabolites)

Program:

Marine Microbiology Initiative (MMI)

Principal Investigator:

Elizabeth Kujawinski (Woods Hole Oceanographic Institution, WHOI)

Technician:

Krista Longnecker (Woods Hole Oceanographic Institution, WHOI)

BCO-DMO Data Manager:

Amber D. York (Woods Hole Oceanographic Institution, WHOI BCO-DMO)

Version:

Version Date:

2021-08-27

Restricted:

Validated:

Yes

Current State:

Final no updates expected

Diatom metabolites under P-limited and P-replete growth from laboratory cultures in July of 2013

Abstract:

Diatom metabolites under P-limited and P-replete growth. Phosphorus limitation is pervasive in the oligotrophic surface ocean and marine microorganisms use different strategies to survive, and thrive, at these low nutrient levels. Eukaryotic algae such as diatoms are extremely sensitive to phosphorus limitation and recent transcriptomics work has suggested that multiple cellular processes are affected under these growth conditions. Metabolomics is the systematic study of intra- and extracellular metabolites, i.e. the end products of microbial metabolism. As such, metabolomics complements genomics and transcriptomics through the identification and quantification of metabolic intermediates that reflect cellular physiology. Here, we applied intracellular metabolomics to examine the differential response of the model diatom Thalassiosira pseudonana to phosphate-replete and phosphate-limited growth conditions. We focused on metabolites from the purine and pyrimidine biochemical pathways, due to their role in phosphorus cycling associated with nucleic acid synthesis. Under phosphate-replete conditions, T. pseudonana stored nucleotides with phosphate moieties such as adenosine 5'-monophosphate (AMP) and, to a lesser extent, inosine 5'-monophosphate (IMP). In contrast, under phosphate-limited conditions, T. pseudonana had higher concentrations of adenine, inosine, and adenosine all of which lack phosphate moieties. Furthermore, based on previously published transcriptomics data, T. pseudonana differentially regulates select genes that can alter these nucleic acid precursors through the gain or loss of the phosphate moiety. Thus, our analysis of the metabolomics and transcriptomics data converged upon the sensitivity of the purine biochemical pathway to phosphorus availability.

Expand/Collapse All

Description

Raw Spectral Data Files are available in the MetaboLights database under study ID "MTBLS154" (https://www.ebi.ac.uk/metabolights/MTBLS154/). Sample, assay, and metabolite information in ISAtab format are also available from that MetaboLights study.

Methods & Sampling

Metadata from "MTBLS154: Phosphorus availability regulates intracellular nucleotides in marine eukaryotic phytoplankton" at https://www.ebi.ac.uk/metabolights/MTBLS154/samples

Sample Collection:

Thalassiosira pseudonana (CCMP number 1335) was cultured axenically in a modified version of L1 media made with Turks Island Salts in order to reduce the background concentration of dissolved organic carbon in the media. The phosphate-replete treatment contained 36 µM PO4 and the phosphate-limited treatment had 0.4 µM PO4. Prior to the experiment, the culture had been maintained through two culture transfers of phosphate-replete or phosphate-limited media. The experiment began with the addition of 30 ml of T. pseudonana in exponential phase to two-thirds of the flasks which contained 300 ml of media. The remaining one-third of the flasks were designated as cell-free controls. Two flasks with cells and one cell-free control for each media (phosphate-replete or phosphate-limited) were sampled at four time points: 0, 2, 8, and 10 days.

Extraction:

The intracellular metabolites were extracted using a method modified from a protocol previously described in Rabinowitz and Kimball (2007). Briefly, the filter was extracted three times with ice-cold extraction solvent (acetonitrile:methanol:water with 0.1 M formic acid, 40:40:20). The combined extracts were neutralized with ammonium hydroxide and dried in a vacufuge.

The samples for the targeted mass spectrometry analysis were re-dissolved in 95:5 (v/v) water:acetonitrile and combined with deuterated biotin (final concentration 0.05 µg/ml)as an internal standard.

For untargeted analysis, the extracts had to undergo an additional de-salting step prior to analysis. Therefore, the dried extracts were re-dissolved in 0.01 M hydrochloric acid and extracted using a 50 mg/1 cc PPL cartridge following the protocol of Dittmar et al. (2008). The resulting methanol extracts were re-dissolved in 95:5 water:acetonitrile and deuterated biotin.

Chromatography:

For targeted metabolomics analysis, the samples were analyzed with a Synergi 4 µm Fusion – RP 80 Å, 150 × 2.00 mm column (Phenomenex, Torrance, CA) coupled to a Thermo Scientific TSQ Vantage Triple Stage Quadrupole Mass Spectrometer. The chromatography gradient was: an initial hold of 95% A (0.1% formic acid in water) : 5% B (0.1% formic acid in acetonitrile) for 2 minutes, ramp to 65% B from 2 to 20 minutes, ramp to 100% B from 20 to 25 min, and hold until 32.5 minutes. The column was re-equilibrated for 7 min between samples with solvent A. Each metabolite was quantified using multiple reaction monitoring (MRM) mode with optimal parameters determined from infusion of authentic standards. Eight-point external calibration curves (0.5, 1, 5, 10, 50, 100, 250, and 500 ng/ml) were generated for each compound by plotting peak area against concentration.

For untargeted metabolomics analysis, LC separation was performed using a Synergi Fusion reversed phase column (Phenomenex, Torrance, CA) with the same gradient as for targeted analysis.

Mass spectroscopy:

For targeted analysis, samples were analyzed with a Thermo Scientific TSQ Vantage Triple Stage Quadrupole Mass Spectrometer. This instrument allows polarity switching between positive and negative ion mode within a single LC run. Analysis of authentic standards was used to determine the optimal ionization mode for each metabolite.

For untargeted analysis, samples were analyzed in both negative and positive ion mode with liquid chromatography (LC) coupled by electrospray ionization to a 7-Tesla Fourier-transform ion cyclotron resonance mass spectrometer (FT-ICR MS). In parallel to the FT acquisition, four data dependent MS/MS scans were collected at nominal mass resolution in the ion trap (LTQ). Samples were analyzed in random order with a pooled sampled run every six samples in order to assess instrument variability.

Metabolite identification:

The targeted metabolomics compound identifications were based on measurements of authentic standards on the same mass spectrometer. Note that the LC/mass spectrometry system cannot distinguish between leucine and isoleucine, therefore the data are presented as 'leucine/isoleucine'.

Data Processing Description

Targeted metabolomics data The resulting data were converted to mzML files using the msConvert tool (Chambers et al., 2012) and processed with MAVEN (Melamud et al., 2010). The concentration of the metabolites in the targeted mass spectrometry data is given in ng/ml. Note that the concentration of these metabolites in the cell-free controls has been subtracted from the corresponding treatment with Thalassiosira.

Untargeted metabolomics data Data were collected as XCalibur RAW files which were converted to mzXML files using the msConvert tool within ProteoWizard (Chambers et al., 2012). Features were extracted from the LC-MS data using XCMS (Smith et al., 2006), where a feature is defined as a unique combination of a mass-to-charge (m/z) ratio and a retention time. Peak finding was performed with the centWave algorithm (Tautenhahn et al., 2008), and only peaks that fit a Gaussian shape were retained. Features were aligned across samples based on retention time and m/z value using the group.nearest function in XCMS; fillPeaks was used to reconsider features missed in the initial peak finding steps. CAMERA was used 1) to find compounds differing by adduct ion and stable isotope composition (Kuhl et al., 2012) and 2) to extract the intensities and m/z values for the associated MS/MS spectra.

More Information about this dataset

Funding Sources

Funding Source	Award Number
Gordon and Betty Moore Foundation: Marine Microbiology Initiative	GBMF3304

Deployments

None available yet

Instruments

Mass Spectrometer

Supplied Name:

Supplied Description:

For targeted analysis, samples were analyzed with a Thermo Scientific TSQ Vantage Triple Stage Quadrupole Mass Spectrometer.

Instrument Type

Generic Name: Mass Spectrometer

Acronym: Mass Spec

Community Identifier: http://vocab.nerc.ac.uk/collection/L05/current/LAB16/

Generic Description:

General term for instruments used to measure the mass-to-charge ratio of ions; generally used to find the composition of a sample by generating a mass spectrum representing the masses of sample components.

Parameters

None available yet

Database

Contribute Data

Dataset: Diatom metabolites